$GENI Retail investors remain sceptical about prospects at #GENinCode, with only 13% take-up of retail offer. Taken together with Placing, gross cash raised was £4.07m. Aiming to use this to generate sales traction. investors.genincode.com/archive/2025/1…

#GENI #GENINCODE One to keep any eye on. NHS order bidstats.uk/tenders/2024/W…

#dnaworldday celebrates the discovery of the #dna double helix structure. Thanks to this discovery, #GenIncode tests now provide information about inherited conditions, disease diagnosis and improved risk assessment in #cardiovasculardisease. #cardioincode #lipidincode

#GENI #GENIncode FDA news is due anytime now. The article below highlights how generic testing can help identify those at risk of cardiovascular disease. sciencedirect.com/science/articl… cardio incode test from genenicode is regarded as “first in class”!

#GENI #GENIncode 177m shares. MC £8.41m 52week H:25p, L4.75 (current) Cash ~£6m Estimated rev 2023 £1.5-2m and growing. •Significant and growing demand for US Early Access Program with over 40 institutions now onboarding for LIPID inCode® for the diagnosis of familial 1/3

#UK: Mid-Market Update ✦#GENinCode (medical software) falls more than -1% as the company raises £4.1 million at £0.05 per share #StockMarket #FTSE100 4/5

#GENI #GENIncode rns files.q4europe.com/news-pdf/34273…

#GENI #GENIncode the RNS this morning does seem remarkable for a small UK company and I guess the US will want stock when their markets open 😎

👉🏻Visit us at our booth nº73 and discover our test THROMBO inCode for hereditary thrombophilia.🧬   📍 Palacio de Congresos de Barcelona 📆 6-8 October 2022, Barcelona, Spain.   #genincode #genetics #hematologia #Hemato2022 #hematology #thromboincode #destacadoSEHH

#AIM Company, Genincode (#GENI.L), down 5.36pc to 26.50p. Visit: google.com/search?q=uk+st… #GENINCODE